Kuwait vs Malta: Reported rate of new cervical cancer cases
Kuwait
3.77 per 100,000 women
in 2017
Malta
2.23 per 100,000 women
in 2017
Kuwait rank
44th
Malta rank
45th
Reported rate of new cervical cancer cases over time
- Kuwait
- Malta
How they compare
Kuwait currently reports 3.77 per 100,000 women against 2.23 per 100,000 women in Malta, a difference of 1.54 per 100,000 women.
That makes Kuwait's figure about 1.7 times Malta's.
The two have swapped places 9 times across 20 shared years of data; in 1998 it was Malta ahead.
Kuwait ranks 44th and Malta ranks 45th of 46 countries.
Across the 3 decades both report, Kuwait averaged higher in 1 and Malta in 2.
Head to head by decade
| Decade | Kuwait | Malta | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 3.69 per 100,000 women | 4.65 per 100,000 women | 0.9627 per 100,000 women | Malta |
| 2000s | 4.17 per 100,000 women | 4.07 per 100,000 women | 0.0975 per 100,000 women | Kuwait |
| 2010s | 2.99 per 100,000 women | 3.97 per 100,000 women | 0.9844 per 100,000 women | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Kuwait or Malta?
- Kuwait, at 3.77 per 100,000 women against 2.23 per 100,000 women in Malta as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Kuwait and Malta?
- 1.54 per 100,000 women, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and Malta?
- 20 years are reported by both, from 1998 to 2017.
- How do Kuwait and Malta rank globally for reported rate of new cervical cancer cases?
- Kuwait ranks 44th and Malta ranks 45th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) β processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.